- Supported exchanges /
- F /
- 4PKB.F
LAVA THERAP. B.V. EO-12 (4PKB F) stock market data APIs
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.
LAVA THERAP. B.V. EO-12 Financial Data Overview
1.57 | |
1.79 | |
- | |
1.79 | |
1.57 | |
1.07-3.66 | |
45 627 K | |
26 297 K | |
7 398 K | |
-0.28 | |
0.504 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
LAVA THERAP. B.V. EO-12 Fundamental Data is available in our Financial Data APIs
- Net Revenue 7 398 K
- EBITDA -26 883 000
- Earnings Per Share -0.82
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get LAVA THERAP. B.V. EO-12 Earnings via APIs
- Latest Release 2021-06-30
- EPS/Forecast -0.27
Get LAVA THERAP. B.V. EO-12 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: